Canino, Fabio
 Distribuzione geografica
Continente #
NA - Nord America 475
EU - Europa 413
AS - Asia 205
SA - Sud America 9
AF - Africa 2
Totale 1.104
Nazione #
US - Stati Uniti d'America 470
IT - Italia 156
SG - Singapore 71
CN - Cina 55
IE - Irlanda 55
GB - Regno Unito 48
HK - Hong Kong 42
DE - Germania 36
SE - Svezia 33
RU - Federazione Russa 25
ID - Indonesia 21
FI - Finlandia 19
LT - Lituania 9
NL - Olanda 8
BR - Brasile 6
CZ - Repubblica Ceca 6
FR - Francia 6
TR - Turchia 4
BG - Bulgaria 3
CR - Costa Rica 3
AT - Austria 2
CA - Canada 2
IL - Israele 2
IN - India 2
NG - Nigeria 2
PL - Polonia 2
TW - Taiwan 2
VE - Venezuela 2
AL - Albania 1
AR - Argentina 1
BE - Belgio 1
DK - Danimarca 1
ES - Italia 1
JP - Giappone 1
KZ - Kazakistan 1
LB - Libano 1
MY - Malesia 1
NO - Norvegia 1
TH - Thailandia 1
VN - Vietnam 1
Totale 1.104
Città #
Santa Clara 185
Singapore 57
Dublin 55
Ashburn 52
Chandler 51
Hong Kong 42
Bologna 34
Enfield 32
Nyköping 25
Fairfield 24
New York 23
Jakarta 20
Helsinki 18
Milan 12
Moscow 12
San Diego 10
Beijing 9
Reggio Emilia 9
Seattle 9
Caprarola 8
Munich 8
Guangzhou 7
Houston 7
Los Angeles 7
Modena 7
Phoenix 7
Shanghai 7
Brno 6
Cardiff 6
Bremen 5
London 5
Sassuolo 5
Savona 5
Florence 4
Frankfurt am Main 4
Lüleburgaz 4
Princeton 4
Wilmington 4
Woodbridge 4
Ann Arbor 3
Nuremberg 3
Palermo 3
Parma 3
San José 3
Sofia 3
Acton 2
Amsterdam 2
Arcola 2
Assago 2
Brooklyn 2
Cambridge 2
Casalgrande 2
Dallas 2
Falkenstein 2
Fidenza 2
Frattamaggiore 2
Lagos 2
Naples 2
Noicattaro 2
Norwalk 2
Padova 2
Rimini 2
Sant'Egidio alla Vibrata 2
Taipei 2
Toronto 2
Vignola 2
Almaty 1
Atlanta 1
Bagnacavallo 1
Bandung 1
Bengaluru 1
Bodh Gaya 1
Brussels 1
Changsha 1
Edinburgh 1
Fiorenzuola D'arda 1
Groningen 1
Guarulhos 1
Hangzhou 1
Hanoi 1
Jerusalem 1
Jiaxing 1
Klang 1
La Guaira 1
Lappeenranta 1
Madrid 1
Manhattan 1
Manoppello 1
Mongaguá 1
Nagold 1
New Orleans 1
Oslo 1
Paris 1
Pisa 1
Recife 1
Rio de Janeiro 1
Rome 1
Salsomaggiore Terme 1
San Cristóbal 1
San Jose 1
Totale 887
Nome #
Thromboembolism (TE) and adjuvant endocrine therapy (AET) in hormone receptor positive (HR+) early breast cancer (EBC): Did the evolution of treatment change the incidence of the adverse event? A metanalysis 132
The Prognostic Role of Early Skeletal Muscle Mass Depletion in Multimodality Management of Patients with Advanced Gastric Cancer Treated with First Line Chemotherapy: A Pilot Experience from Modena Cancer Center 128
TDM-1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: A meta-analysis 122
Targeting PI3K/AKT/mTOR Pathway in Breast Cancer: From Biology to Clinical Challenges 114
T-DM1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis. 90
Next Generation Sequencing (NGS): a possible game changer in metastatic breast cancer 81
Adding weekly carboplatin to sequential anthracycline and paclitaxel-based chemotherapy as neoadjuvant treatment for triple negative breast cancer (TNBC) patients: a propensity scorematched study 69
Cemiplimab- and nivolumab-induced myasthenia gravis: two clinical cases 69
Role of Intrinsic Subtype Analysis with PAM50 in Hormone Receptors Positive HER2 Negative Metastatic Breast Cancer: A Systematic Review. 66
Real-World Data and Clinical Implications of Next-Generation Sequencing (NGS)-Based Analysis in Metastatic Breast Cancer Patients 57
Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation 50
Correction: Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation (British Journal of Cancer, (2023), 128, 2, (266-274), 10.1038/s41416-022-02050-8) 44
Atezolizumab-Related Sarcoidosis-Like Reaction in Early Breast Cancer Patient: Know It To Diagnose It: A Case Report with Review of the Literature 35
TDM-1 efficacy in trastuzumabpertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis 33
Thromboembolism and Adjuvant Endocrine Therapy (AET) in Hormone Receptor-Positive Early Breast Cancer (EBC): Did Treatment Evolution Change Incidence of the Adverse Event? A Meta-Analysis 26
Safety and efficacy analysis of neoadjuvant pertuzumab, trastuzumab and standard chemotherapy for HER2–positive early breast cancer: real–world data from NeoPowER study 5
Totale 1.121
Categoria #
all - tutte 7.515
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.515


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022118 0 34 2 1 11 1 6 15 9 2 19 18
2022/2023286 15 25 10 17 20 18 6 12 68 2 83 10
2023/2024298 22 14 27 31 22 31 41 20 16 7 34 33
2024/2025419 22 3 22 66 145 123 38 0 0 0 0 0
Totale 1.121